FHAM
EBS icon

Folger Hill Asset Management’s Emergent Biosolutions EBS Stock Holding History

Folger Hill Asset Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-10,332
Closed -$339K – 328
2016
Q4 		$339K Buy
+10,332
New +$310K 0.03% 233

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Folger Hill Asset Management's EBS Position: Q1 2017 in Review

Folger Hill Asset Management sold out of Emergent Biosolutions (EBS) in Q1 2017, closing a stake of 10,332 shares — an estimated $339K sold.

Folger Hill Asset Management first reported a position in EBS in Q4 2016 and held it in 1 quarter. The position peaked at $339K in Q4 2016. 176 funds tracked by Wall St. Rank hold EBS as of Q1 2017.

  • Folger Hill Asset Management reported no remaining Emergent Biosolutions position as of Q1 2017 after selling out during the quarter.
  • Folger Hill Asset Management sold 10,332 Emergent Biosolutions shares in Q1 2017, an estimated $339K.
  • Folger Hill Asset Management first reported a position in Emergent Biosolutions in Q4 2016 and held it in 1 quarter.
  • Folger Hill Asset Management's Emergent Biosolutions position peaked at $339K in Q4 2016.
  • 176 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2017.

Based on Folger Hill Asset Management's 13F filing for Q1 2017, filed 15 May 2017.